An automatic domestic device designed to perform indirect cardiac massage during resuscitation has been successfully created in Moscow. This technical solution is designed to free up the hands of doctors to carry out other urgent measures to save patients. Sergey Sobyanin, the Mayor of Moscow, spoke about the new product, which was developed at Medplant LLC (residents of Technopolis Moscow).
Experts say that this device will significantly increase the chances of patient survival and improve the quality of medical care provided. According to Sergei Sobyanin, who presented the novelty to the general public today, a distinctive feature of the development is the lack of analogues in Russia.
The device has no analogues in Russia and has a number of advantages compared to foreign systems. For example, it is lighter because it is made of modern materials, and more convenient to use due to the operation on two batteries.
The installation of the system from Medplant takes only 20 seconds, which makes it highly effective in situations requiring urgent intervention. The developers' immediate plans include the creation of a unique resuscitation complex that will interact with the ventilator, which will allow for the most effective emergency medical care.
It is worth noting that in mid-summer, the Roselectronics holding of the Rostec State Corporationpresented a prototype of its "CardioRobot" - an "automated device for indirect cardiac massage during cardiopulmonary resuscitation." The Rostec device is equipped with sensors that regulate pressure and compression depth depending on the patient's vital signs. According to the company, the main advantages of the device were the fact that the "CardioRobot" can work up to 45 minutes on battery power, while a qualified specialist can maintain high-quality indirect massage for only 2-3 minutes. In addition, the CardioRobot is additionally equipped with a cuff for non-invasive blood pressure measurement and an SpO2 sensor.
The CardioRobot project is being developed by NPP Almaz with the support of the Ministry of Industry and Trade of Russia. Mikhail Apin, General Director of NPP Almaz, stated that the company already has more than 1,500 applications for the purchase of these devices for cardiopulmonary resuscitation. The start of mass production of the CardioRobot was expected in 2025.
Rostec also plans toestablish mass production of portable ventilators, but who knows, maybe the Technopolis enterprise will overtake the giant state corporation here as well.